Cleared Traditional

K191331 - Life Sensor Cardiac Monitor

K191331 is the FDA 510(k) clearance for Life Sensor Cardiac Monitor by Braveheart Wireless, Inc.. It is a Class 2 Cardiovascular device (product code DRG) cleared through the Traditional 510(k) pathway after a 27-day FDA review.

K191331 · Braveheart Wireless, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2019
Decision
27d
Days
Class 2
Risk

K191331 is an FDA 510(k) clearance for the Life Sensor Cardiac Monitor. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Braveheart Wireless, Inc. (Nashua, US). The FDA issued a Cleared decision on June 12, 2019 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Braveheart Wireless, Inc. devices

Submission Details

510(k) Number K191331 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 16, 2019
Decision Date June 12, 2019
Days to Decision 27 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d faster than avg
Panel avg: 125d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Accelerated Device Approval Services
Rafael Aguila

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 71
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K191331.
VitalPatch 5D Biosensor - single, VitalPatch 7D Biosensor - single, VitalPatch 5D Biosensor – bag of 20, VitalPatch 7D Biosensor – bag of 20
K192757 · Vitalconnect, Inc. · Feb 2020
VV330 Continuous ECG Platform, VivaLNK Adhesive Patch
K191870 · VivaLNK, Inc. · Jan 2020
BioSticker System
K191614 · Biointellisense, Inc. · Dec 2019
VitalPatch 7D Biosensor - single, VitalPatch 7D Biosensor - bag of 20
K190916 · Vitalconnect, Inc. · Jun 2019
VitalConnect Platform, VitalPatch Biosensor
K183078 · Vitalconnect, Inc. · Mar 2019
Surveyor S2
K182297 · Mortara Instrument, Inc. · Jan 2019